Cleantech Transit, Inc. (CLNO)
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit, Inc. (CLNO) is pleased to announce it has met its funding requirement to secure the Company’s ability to earn in 25% of the 500KW Merced Project.
The Company is in the final stages of closing its initial interest in the Merced Project and is currently working on completing the necessary documentation and expects closing the transaction soon. As previously announced Cleantech has the option to earn up to 40% of the Merced Project and the Company plans to continue to work towards increasing its interest in the Merced Project as they move ahead.
Bioethanol is an alcohol made by fermenting the sugar components of plant materials and it is made mostly from sugar and starch crops. With advanced technology being developed, cellulosic biomass, such as trees and grasses, are also used as feedstocks for ethanol production.
Ethanol can be used as a fuel for vehicles in its pure form, but it is usually used as a gasoline additive to increase octane and improve vehicle emissions. Biodiesel is made from vegetable oils, animal fats or recycled greases.
Biodiesel can be used as a fuel for vehicles in its pure form, but it is usually used as a diesel additive to reduce levels of particulates, carbon monoxide, and hydrocarbons from diesel-powered vehicles. Biodiesel is produced from oils or fats and is the most common biofuel in Europe.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
Host Hotels & Resorts, Inc. (NYSE:HST) announced that its board of directors authorized a regular quarterly cash dividend of $0.04 per share on the Company’s common stock, an increase of $0.01 from the previous quarter. The dividend is payable on October 17, 2011 to stockholders of record on September 30, 2011.
Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm primarily engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States.
Corning Inc. (NYSE:GLW) its Board of Directors declared a 50% increase in the company’s quarterly common stock dividend. Corning’s quarterly dividend will rise to $0.075 per share of common stock held, versus $0.05 per share previously. The fourth-quarter dividend will be payable on Dec. 16, 2011 to holders of record Nov. 16, 2011.
Corning Incorporated manufactures and processes specialty glass and ceramics products worldwide.
Enzo Biochem, Inc. (ENZ)
Biotechnology encompasses any technology using microorganisms or the cells of vegetable matter, animals or humans. It helps to understand that modern biotechnology allows a single gene (from a strand of thousands of genes) to be changed, while traditional breeding involved random mixtures of many genes. Also, some end products of biotechnology (such as corn syrup or soybean oil) do not contain any genes; they are merely products of gene action. Biotechnology aims to ensure that biotechnology for medical applications is best utilized for the benefit of a society with a place for everyone.
Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.
Enzo Biochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.
The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D’Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.
Over the past two years, Enzo has been engaged in enhancing the Life Sciences subsidiary’s operating performance through added capabilities, greater integration and a more focused product mix. These efforts are all aimed at significantly expanding Enzo’s presence and marketing beyond the traditional academic and research laboratory core to greater penetrate the pharmaceutical and clinical customer base with new and cutting edge platform technologies.
For more information about Enzo Biochem Inc. visit its website: http://www.enzo.com
El Paso Corp. (NYSE:EP) the board of directors of El Paso Corporation (NYSE: EP) declared a quarterly dividend of $0.01 per share on the company’s outstanding common stock. The dividend will be payable January 3, 2012 to shareholders of record as of the close of business on December 2, 2011. Outstanding shares of common stock entitled to receive dividends as of September 30, 2011 were 770,482,626.
El Paso Corporation operates in the natural gas transmission, and exploration and production sectors of the energy industry primarily in the United States.
No comments:
Post a Comment